Almost 50% of Asian lung cancer patients harbor tumors with TKI-sensitizing EGFR mutation positive NSCLC [36,37], whereas prevalence of the EGFR mutations in Western lung cancer patients was about 15% [38]. The gene discussed is EGFR; the disease is lung cancer.